#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Association between Thalamocortical Functional Connectivity Abnormalities and Cognitive Deficits in Schizophrenia Cognitive deficits are considered a core component of schizophrenia and may predict functional outcome.
1-1	0-11	Association	_
1-2	12-19	between	_
1-3	20-35	Thalamocortical	_
1-4	36-46	Functional	_
1-5	47-59	Connectivity	_
1-6	60-73	Abnormalities	_
1-7	74-77	and	_
1-8	78-87	Cognitive	_
1-9	88-96	Deficits	_
1-10	97-99	in	_
1-11	100-113	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-12	114-123	Cognitive	_
1-13	124-132	deficits	_
1-14	133-136	are	_
1-15	137-147	considered	_
1-16	148-149	a	_
1-17	150-154	core	_
1-18	155-164	component	_
1-19	165-167	of	_
1-20	168-181	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-21	182-185	and	_
1-22	186-189	may	_
1-23	190-197	predict	_
1-24	198-208	functional	_
1-25	209-216	outcome	_
1-26	217-218	.	_

Text=However, the neural underpinnings of neuropsychological impairment remain to be fully elucidated.
2-1	219-226	However	_
2-2	227-228	,	_
2-3	229-232	the	_
2-4	233-239	neural	_
2-5	240-253	underpinnings	_
2-6	254-256	of	_
2-7	257-275	neuropsychological	_
2-8	276-286	impairment	_
2-9	287-293	remain	_
2-10	294-296	to	_
2-11	297-299	be	_
2-12	300-305	fully	_
2-13	306-316	elucidated	_
2-14	317-318	.	_

Text=Data of 59 schizophrenia patients and 72 healthy controls from a public resting-state fMRI database was employed in our study.
3-1	319-323	Data	_
3-2	324-326	of	_
3-3	327-329	59	_
3-4	330-343	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-5	344-352	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-6	353-356	and	_
3-7	357-359	72	_
3-8	360-367	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
3-9	368-376	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
3-10	377-381	from	_
3-11	382-383	a	_
3-12	384-390	public	_
3-13	391-404	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
3-14	405-409	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
3-15	410-418	database	_
3-16	419-422	was	_
3-17	423-431	employed	_
3-18	432-434	in	_
3-19	435-438	our	_
3-20	439-444	study	_
3-21	445-446	.	_

Text=Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery was used to measure deficits of cognitive abilities in schizophrenia.
4-1	447-458	Measurement	_
4-2	459-462	and	_
4-3	463-472	Treatment	_
4-4	473-481	Research	_
4-5	482-484	to	_
4-6	485-492	Improve	_
4-7	493-502	Cognition	_
4-8	503-505	in	_
4-9	506-519	Schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-10	520-521	(	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-11	522-529	MATRICS	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-12	530-531	)	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-13	532-539	Battery	_
4-14	540-543	was	_
4-15	544-548	used	_
4-16	549-551	to	_
4-17	552-559	measure	_
4-18	560-568	deficits	_
4-19	569-571	of	_
4-20	572-581	cognitive	_
4-21	582-591	abilities	_
4-22	592-594	in	_
4-23	595-608	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-24	609-610	.	_

Text=Neural correlates of cognitive deficits in schizophrenia were examined by linear regression analysis of the thalamocortical network activity with scores of seven cognitive domains.
5-1	611-617	Neural	_
5-2	618-628	correlates	_
5-3	629-631	of	_
5-4	632-641	cognitive	_
5-5	642-650	deficits	_
5-6	651-653	in	_
5-7	654-667	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-8	668-672	were	_
5-9	673-681	examined	_
5-10	682-684	by	_
5-11	685-691	linear	_
5-12	692-702	regression	_
5-13	703-711	analysis	_
5-14	712-714	of	_
5-15	715-718	the	_
5-16	719-734	thalamocortical	_
5-17	735-742	network	_
5-18	743-751	activity	_
5-19	752-756	with	_
5-20	757-763	scores	_
5-21	764-766	of	_
5-22	767-772	seven	_
5-23	773-782	cognitive	_
5-24	783-790	domains	_
5-25	791-792	.	_

Text=We confirmed the combination of reduced prefrontal-thalamic connectivity and increased sensorimotor-thalamic connectivity in patients with schizophrenia.
6-1	793-795	We	_
6-2	796-805	confirmed	_
6-3	806-809	the	_
6-4	810-821	combination	_
6-5	822-824	of	_
6-6	825-832	reduced	_
6-7	833-852	prefrontal-thalamic	_
6-8	853-865	connectivity	_
6-9	866-869	and	_
6-10	870-879	increased	_
6-11	880-901	sensorimotor-thalamic	_
6-12	902-914	connectivity	_
6-13	915-917	in	_
6-14	918-926	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
6-15	927-931	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
6-16	932-945	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
6-17	946-947	.	_

Text=Correlation analysis with cognition revealed that in schizophrenia (1) the thalamic functional connectivity in the bilateral pre- and postcentral gyri was negatively correlated with attention/vigilance and speed of processing (Pearson ’ s r ≤ −0.443, p ≤ 0.042, FWE corrected), and positively correlated with patients ’ negative symptoms (Pearson ’ s r ≥ 0.375, p ≤ 0.003, FWE corrected); (2) the thalamic functional connectivity in the right cerebellum was positively correlated with speed of processing (Pearson ’ s r = 0.388, p = 0.01, FWE corrected).
7-1	948-959	Correlation	_
7-2	960-968	analysis	_
7-3	969-973	with	_
7-4	974-983	cognition	_
7-5	984-992	revealed	_
7-6	993-997	that	_
7-7	998-1000	in	_
7-8	1001-1014	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
7-9	1015-1016	(	_
7-10	1017-1018	1	_
7-11	1019-1020	)	_
7-12	1021-1024	the	_
7-13	1025-1033	thalamic	_
7-14	1034-1044	functional	_
7-15	1045-1057	connectivity	_
7-16	1058-1060	in	_
7-17	1061-1064	the	_
7-18	1065-1074	bilateral	_
7-19	1075-1079	pre-	_
7-20	1080-1083	and	_
7-21	1084-1095	postcentral	_
7-22	1096-1100	gyri	_
7-23	1101-1104	was	_
7-24	1105-1115	negatively	_
7-25	1116-1126	correlated	_
7-26	1127-1131	with	_
7-27	1132-1151	attention/vigilance	_
7-28	1152-1155	and	_
7-29	1156-1161	speed	_
7-30	1162-1164	of	_
7-31	1165-1175	processing	_
7-32	1176-1177	(	_
7-33	1178-1185	Pearson	_
7-34	1186-1187	’	_
7-35	1188-1189	s	_
7-36	1190-1191	r	_
7-37	1192-1193	≤	_
7-38	1194-1200	−0.443	_
7-39	1201-1202	,	_
7-40	1203-1204	p	_
7-41	1205-1206	≤	_
7-42	1207-1212	0.042	_
7-43	1213-1214	,	_
7-44	1215-1218	FWE	_
7-45	1219-1228	corrected	_
7-46	1229-1230	)	_
7-47	1231-1232	,	_
7-48	1233-1236	and	_
7-49	1237-1247	positively	_
7-50	1248-1258	correlated	_
7-51	1259-1263	with	_
7-52	1264-1272	patients	_
7-53	1273-1274	’	_
7-54	1275-1283	negative	_
7-55	1284-1292	symptoms	_
7-56	1293-1294	(	_
7-57	1295-1302	Pearson	_
7-58	1303-1304	’	_
7-59	1305-1306	s	_
7-60	1307-1308	r	_
7-61	1309-1310	≥	_
7-62	1311-1316	0.375	_
7-63	1317-1318	,	_
7-64	1319-1320	p	_
7-65	1321-1322	≤	_
7-66	1323-1328	0.003	_
7-67	1329-1330	,	_
7-68	1331-1334	FWE	_
7-69	1335-1344	corrected	_
7-70	1345-1346	)	_
7-71	1347-1348	;	_
7-72	1349-1350	(	_
7-73	1351-1352	2	_
7-74	1353-1354	)	_
7-75	1355-1358	the	_
7-76	1359-1367	thalamic	_
7-77	1368-1378	functional	_
7-78	1379-1391	connectivity	_
7-79	1392-1394	in	_
7-80	1395-1398	the	_
7-81	1399-1404	right	_
7-82	1405-1415	cerebellum	_
7-83	1416-1419	was	_
7-84	1420-1430	positively	_
7-85	1431-1441	correlated	_
7-86	1442-1446	with	_
7-87	1447-1452	speed	_
7-88	1453-1455	of	_
7-89	1456-1466	processing	_
7-90	1467-1468	(	_
7-91	1469-1476	Pearson	_
7-92	1477-1478	’	_
7-93	1479-1480	s	_
7-94	1481-1482	r	_
7-95	1483-1484	=	_
7-96	1485-1490	0.388	_
7-97	1491-1492	,	_
7-98	1493-1494	p	_
7-99	1495-1496	=	_
7-100	1497-1501	0.01	_
7-101	1502-1503	,	_
7-102	1504-1507	FWE	_
7-103	1508-1517	corrected	_
7-104	1518-1519	)	_
7-105	1520-1521	.	_

Text=Our study demonstrates that thalamic hyperconnectivity with sensorimotor areas is related to the severity of cognitive deficits and clinical symptoms, and extends our understanding of the neural underpinnings of “ cognitive dysmetria ” in schizophrenia.
8-1	1522-1525	Our	_
8-2	1526-1531	study	_
8-3	1532-1544	demonstrates	_
8-4	1545-1549	that	_
8-5	1550-1558	thalamic	_
8-6	1559-1576	hyperconnectivity	_
8-7	1577-1581	with	_
8-8	1582-1594	sensorimotor	_
8-9	1595-1600	areas	_
8-10	1601-1603	is	_
8-11	1604-1611	related	_
8-12	1612-1614	to	_
8-13	1615-1618	the	_
8-14	1619-1627	severity	_
8-15	1628-1630	of	_
8-16	1631-1640	cognitive	_
8-17	1641-1649	deficits	_
8-18	1650-1653	and	_
8-19	1654-1662	clinical	_
8-20	1663-1671	symptoms	_
8-21	1672-1673	,	_
8-22	1674-1677	and	_
8-23	1678-1685	extends	_
8-24	1686-1689	our	_
8-25	1690-1703	understanding	_
8-26	1704-1706	of	_
8-27	1707-1710	the	_
8-28	1711-1717	neural	_
8-29	1718-1731	underpinnings	_
8-30	1732-1734	of	_
8-31	1735-1736	“	_
8-32	1737-1746	cognitive	_
8-33	1747-1756	dysmetria	_
8-34	1757-1758	”	_
8-35	1759-1761	in	_
8-36	1762-1775	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
8-37	1776-1777	.	_

Text=Methods Participants An open access resting-state fMRI dataset of schizophrenia patients and healthy subjects, formerly studied by different authors, was employed in our study.
9-1	1778-1785	Methods	http://maven.renci.org/NeuroBridge/neurobridge#DataCollectionMethod
9-2	1786-1798	Participants	_
9-3	1799-1801	An	_
9-4	1802-1806	open	_
9-5	1807-1813	access	_
9-6	1814-1827	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
9-7	1828-1832	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
9-8	1833-1840	dataset	_
9-9	1841-1843	of	_
9-10	1844-1857	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
9-11	1858-1866	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
9-12	1867-1870	and	_
9-13	1871-1878	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
9-14	1879-1887	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
9-15	1888-1889	,	_
9-16	1890-1898	formerly	_
9-17	1899-1906	studied	_
9-18	1907-1909	by	_
9-19	1910-1919	different	_
9-20	1920-1927	authors	_
9-21	1928-1929	,	_
9-22	1930-1933	was	_
9-23	1934-1942	employed	_
9-24	1943-1945	in	_
9-25	1946-1949	our	_
9-26	1950-1955	study	_
9-27	1956-1957	.	_

Text=This publicly available dataset is maintained by the Center for Biomedical Research Excellence (COBRE, http: //fcon_1000.projects.nitrc.org/indi/retro/cobre.html).
10-1	1958-1962	This	_
10-2	1963-1971	publicly	_
10-3	1972-1981	available	_
10-4	1982-1989	dataset	_
10-5	1990-1992	is	_
10-6	1993-2003	maintained	_
10-7	2004-2006	by	_
10-8	2007-2010	the	_
10-9	2011-2017	Center	_
10-10	2018-2021	for	_
10-11	2022-2032	Biomedical	_
10-12	2033-2041	Research	_
10-13	2042-2052	Excellence	_
10-14	2053-2054	(	_
10-15	2055-2060	COBRE	_
10-16	2061-2062	,	_
10-17	2063-2067	http	_
10-18	2068-2069	:	_
10-19	2070-2122	//fcon_1000.projects.nitrc.org/indi/retro/cobre.html	_
10-20	2123-2124	)	_
10-21	2125-2126	.	_

Text=Patients were recruited from the outpatient clinic at the University of New Mexico Health Sciences Center.
11-1	2127-2135	Patients	_
11-2	2136-2140	were	_
11-3	2141-2150	recruited	_
11-4	2151-2155	from	_
11-5	2156-2159	the	_
11-6	2160-2170	outpatient	_
11-7	2171-2177	clinic	_
11-8	2178-2180	at	_
11-9	2181-2184	the	_
11-10	2185-2195	University	_
11-11	2196-2198	of	_
11-12	2199-2202	New	_
11-13	2203-2209	Mexico	_
11-14	2210-2216	Health	_
11-15	2217-2225	Sciences	_
11-16	2226-2232	Center	_
11-17	2233-2234	.	_

Text=A psychiatrist made judgments about whether patients were clinically stable and appropriate for the study.
12-1	2235-2236	A	_
12-2	2237-2249	psychiatrist	_
12-3	2250-2254	made	_
12-4	2255-2264	judgments	_
12-5	2265-2270	about	_
12-6	2271-2278	whether	_
12-7	2279-2287	patients	_
12-8	2288-2292	were	_
12-9	2293-2303	clinically	_
12-10	2304-2310	stable	_
12-11	2311-2314	and	_
12-12	2315-2326	appropriate	_
12-13	2327-2330	for	_
12-14	2331-2334	the	_
12-15	2335-2340	study	_
12-16	2341-2342	.	_

Text=Participants were administered the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV SCID–Clinician Version) by a trained research assistant, and the interview process was supervised by either F. M. Hanlon or J. R. Bustillo.
13-1	2343-2355	Participants	_
13-2	2356-2360	were	_
13-3	2361-2373	administered	_
13-4	2374-2377	the	_
13-5	2378-2388	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
13-6	2389-2397	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
13-7	2398-2407	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
13-8	2408-2411	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
13-9	2412-2415	the	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
13-10	2416-2426	Diagnostic	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
13-11	2427-2430	and	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
13-12	2431-2442	Statistical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
13-13	2443-2449	Manual	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
13-14	2450-2452	of	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
13-15	2453-2459	Mental	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
13-16	2460-2469	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
13-17	2470-2471	,	_
13-18	2472-2475	4th	_
13-19	2476-2483	edition	_
13-20	2484-2485	(	_
13-21	2486-2492	DSM-IV	_
13-22	2493-2507	SCID–Clinician	_
13-23	2508-2515	Version	_
13-24	2516-2517	)	_
13-25	2518-2520	by	_
13-26	2521-2522	a	_
13-27	2523-2530	trained	_
13-28	2531-2539	research	_
13-29	2540-2549	assistant	_
13-30	2550-2551	,	_
13-31	2552-2555	and	_
13-32	2556-2559	the	_
13-33	2560-2569	interview	_
13-34	2570-2577	process	_
13-35	2578-2581	was	_
13-36	2582-2592	supervised	_
13-37	2593-2595	by	_
13-38	2596-2602	either	_
13-39	2603-2605	F.	_
13-40	2606-2608	M.	_
13-41	2609-2615	Hanlon	_
13-42	2616-2618	or	_
13-43	2619-2621	J.	_
13-44	2622-2624	R.	_
13-45	2625-2633	Bustillo	_
13-46	2634-2635	.	_

Text=The patients ’ exclusion criteria were as follows: history of neurological disorder, mental retardation, severe head trauma with more than 5-minute loss of consciousness, and substance abuse or dependence within the last 12 months.
14-1	2636-2639	The	_
14-2	2640-2648	patients	_
14-3	2649-2650	’	_
14-4	2651-2660	exclusion	_
14-5	2661-2669	criteria	_
14-6	2670-2674	were	_
14-7	2675-2677	as	_
14-8	2678-2685	follows	_
14-9	2686-2687	:	_
14-10	2688-2695	history	_
14-11	2696-2698	of	_
14-12	2699-2711	neurological	_
14-13	2712-2720	disorder	_
14-14	2721-2722	,	_
14-15	2723-2729	mental	_
14-16	2730-2741	retardation	_
14-17	2742-2743	,	_
14-18	2744-2750	severe	_
14-19	2751-2755	head	_
14-20	2756-2762	trauma	_
14-21	2763-2767	with	_
14-22	2768-2772	more	_
14-23	2773-2777	than	_
14-24	2778-2786	5-minute	_
14-25	2787-2791	loss	_
14-26	2792-2794	of	_
14-27	2795-2808	consciousness	_
14-28	2809-2810	,	_
14-29	2811-2814	and	_
14-30	2815-2824	substance	_
14-31	2825-2830	abuse	_
14-32	2831-2833	or	_
14-33	2834-2844	dependence	_
14-34	2845-2851	within	_
14-35	2852-2855	the	_
14-36	2856-2860	last	_
14-37	2861-2863	12	_
14-38	2864-2870	months	_
14-39	2871-2872	.	_

Text=The controls ’ exclusion criterion was having any psychiatric dysfunction.
15-1	2873-2876	The	_
15-2	2877-2885	controls	_
15-3	2886-2887	’	_
15-4	2888-2897	exclusion	_
15-5	2898-2907	criterion	_
15-6	2908-2911	was	_
15-7	2912-2918	having	_
15-8	2919-2922	any	_
15-9	2923-2934	psychiatric	_
15-10	2935-2946	dysfunction	_
15-11	2947-2948	.	_

Text=Informed consent was obtained from all subjects, according to institutional guidelines required by the Institutional Review Board at the University of New Mexico.
16-1	2949-2957	Informed	_
16-2	2958-2965	consent	_
16-3	2966-2969	was	_
16-4	2970-2978	obtained	_
16-5	2979-2983	from	_
16-6	2984-2987	all	_
16-7	2988-2996	subjects	_
16-8	2997-2998	,	_
16-9	2999-3008	according	_
16-10	3009-3011	to	_
16-11	3012-3025	institutional	_
16-12	3026-3036	guidelines	_
16-13	3037-3045	required	_
16-14	3046-3048	by	_
16-15	3049-3052	the	_
16-16	3053-3066	Institutional	_
16-17	3067-3073	Review	_
16-18	3074-3079	Board	_
16-19	3080-3082	at	_
16-20	3083-3086	the	_
16-21	3087-3097	University	_
16-22	3098-3100	of	_
16-23	3101-3104	New	_
16-24	3105-3111	Mexico	_
16-25	3112-3113	.	_

Text=All experiments were performed in accordance with relevant guidelines and regulations.
17-1	3114-3117	All	_
17-2	3118-3129	experiments	_
17-3	3130-3134	were	_
17-4	3135-3144	performed	_
17-5	3145-3147	in	_
17-6	3148-3158	accordance	_
17-7	3159-3163	with	_
17-8	3164-3172	relevant	_
17-9	3173-3183	guidelines	_
17-10	3184-3187	and	_
17-11	3188-3199	regulations	_
17-12	3200-3201	.	_

Text=Neuropsychological Measures Premorbid intelligence was assessed by the Wechsler Test of Adult Reading (WTAR) and intellectual functioning was assessed by the Wechsler Abbreviated Scale of Intelligence (WASI), a short and reliable measure of intelligence.
18-1	3202-3220	Neuropsychological	_
18-2	3221-3229	Measures	_
18-3	3230-3239	Premorbid	_
18-4	3240-3252	intelligence	_
18-5	3253-3256	was	_
18-6	3257-3265	assessed	_
18-7	3266-3268	by	_
18-8	3269-3272	the	_
18-9	3273-3281	Wechsler	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
18-10	3282-3286	Test	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
18-11	3287-3289	of	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
18-12	3290-3295	Adult	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
18-13	3296-3303	Reading	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
18-14	3304-3305	(	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
18-15	3306-3310	WTAR	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
18-16	3311-3312	)	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
18-17	3313-3316	and	_
18-18	3317-3329	intellectual	_
18-19	3330-3341	functioning	_
18-20	3342-3345	was	_
18-21	3346-3354	assessed	_
18-22	3355-3357	by	_
18-23	3358-3361	the	_
18-24	3362-3370	Wechsler	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
18-25	3371-3382	Abbreviated	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
18-26	3383-3388	Scale	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
18-27	3389-3391	of	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
18-28	3392-3404	Intelligence	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
18-29	3405-3406	(	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
18-30	3407-3411	WASI	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
18-31	3412-3413	)	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
18-32	3414-3415	,	_
18-33	3416-3417	a	_
18-34	3418-3423	short	_
18-35	3424-3427	and	_
18-36	3428-3436	reliable	_
18-37	3437-3444	measure	_
18-38	3445-3447	of	_
18-39	3448-3460	intelligence	_
18-40	3461-3462	.	_

Text=Of the WASI subtests, the Vocabulary and Similarities tests were used to estimate verbal IQ (VIQ), Block Design and Matrix Reasoning were used to estimate performance IQ (PIQ), and full-scale IQ (FSIQ) was computed by averaging the PIQ and VIQ scores.
19-1	3463-3465	Of	_
19-2	3466-3469	the	_
19-3	3470-3474	WASI	_
19-4	3475-3483	subtests	_
19-5	3484-3485	,	_
19-6	3486-3489	the	_
19-7	3490-3500	Vocabulary	_
19-8	3501-3504	and	_
19-9	3505-3517	Similarities	_
19-10	3518-3523	tests	_
19-11	3524-3528	were	_
19-12	3529-3533	used	_
19-13	3534-3536	to	_
19-14	3537-3545	estimate	_
19-15	3546-3552	verbal	_
19-16	3553-3555	IQ	_
19-17	3556-3557	(	_
19-18	3558-3561	VIQ	_
19-19	3562-3563	)	_
19-20	3564-3565	,	_
19-21	3566-3571	Block	_
19-22	3572-3578	Design	_
19-23	3579-3582	and	_
19-24	3583-3589	Matrix	_
19-25	3590-3599	Reasoning	_
19-26	3600-3604	were	_
19-27	3605-3609	used	_
19-28	3610-3612	to	_
19-29	3613-3621	estimate	_
19-30	3622-3633	performance	_
19-31	3634-3636	IQ	_
19-32	3637-3638	(	_
19-33	3639-3642	PIQ	_
19-34	3643-3644	)	_
19-35	3645-3646	,	_
19-36	3647-3650	and	_
19-37	3651-3661	full-scale	_
19-38	3662-3664	IQ	_
19-39	3665-3666	(	_
19-40	3667-3671	FSIQ	_
19-41	3672-3673	)	_
19-42	3674-3677	was	_
19-43	3678-3686	computed	_
19-44	3687-3689	by	_
19-45	3690-3699	averaging	_
19-46	3700-3703	the	_
19-47	3704-3707	PIQ	_
19-48	3708-3711	and	_
19-49	3712-3715	VIQ	_
19-50	3716-3722	scores	_
19-51	3723-3724	.	_

Text=The MATRICS consensus cognitive battery consists of seven separable factors, including attention/vigilance, problem solving, speed of processing, social cognition, verbal learning, visual learning, and working memory.
20-1	3725-3728	The	_
20-2	3729-3736	MATRICS	http://maven.renci.org/NeuroBridge/neurobridge#PediatricSleepQuestionnaire
20-3	3737-3746	consensus	_
20-4	3747-3756	cognitive	_
20-5	3757-3764	battery	_
20-6	3765-3773	consists	_
20-7	3774-3776	of	_
20-8	3777-3782	seven	_
20-9	3783-3792	separable	_
20-10	3793-3800	factors	_
20-11	3801-3802	,	_
20-12	3803-3812	including	_
20-13	3813-3832	attention/vigilance	_
20-14	3833-3834	,	_
20-15	3835-3842	problem	_
20-16	3843-3850	solving	_
20-17	3851-3852	,	_
20-18	3853-3858	speed	_
20-19	3859-3861	of	_
20-20	3862-3872	processing	_
20-21	3873-3874	,	_
20-22	3875-3881	social	_
20-23	3882-3891	cognition	_
20-24	3892-3893	,	_
20-25	3894-3900	verbal	_
20-26	3901-3909	learning	_
20-27	3910-3911	,	_
20-28	3912-3918	visual	_
20-29	3919-3927	learning	_
20-30	3928-3929	,	_
20-31	3930-3933	and	_
20-32	3934-3941	working	_
20-33	3942-3948	memory	_
20-34	3949-3950	.	_

Text=Here, t-scores were used for MATRICS, and lower scores indicated greater impairments in cognitive functions.
21-1	3951-3955	Here	_
21-2	3956-3957	,	_
21-3	3958-3966	t-scores	_
21-4	3967-3971	were	_
21-5	3972-3976	used	_
21-6	3977-3980	for	_
21-7	3981-3988	MATRICS	_
21-8	3989-3990	,	_
21-9	3991-3994	and	_
21-10	3995-4000	lower	_
21-11	4001-4007	scores	_
21-12	4008-4017	indicated	_
21-13	4018-4025	greater	_
21-14	4026-4037	impairments	_
21-15	4038-4040	in	_
21-16	4041-4050	cognitive	_
21-17	4051-4060	functions	_
21-18	4061-4062	.	_

Text=Additionally, patients were also assessed with the Positive and Negative Syndrome Scale (PANSS) to quantify the severity of psychosis symptoms.
22-1	4063-4075	Additionally	_
22-2	4076-4077	,	_
22-3	4078-4086	patients	_
22-4	4087-4091	were	_
22-5	4092-4096	also	_
22-6	4097-4105	assessed	_
22-7	4106-4110	with	_
22-8	4111-4114	the	_
22-9	4115-4123	Positive	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-10	4124-4127	and	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-11	4128-4136	Negative	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-12	4137-4145	Syndrome	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-13	4146-4151	Scale	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-14	4152-4153	(	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-15	4154-4159	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-16	4160-4161	)	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
22-17	4162-4164	to	_
22-18	4165-4173	quantify	_
22-19	4174-4177	the	_
22-20	4178-4186	severity	_
22-21	4187-4189	of	_
22-22	4190-4199	psychosis	_
22-23	4200-4208	symptoms	_
22-24	4209-4210	.	_

Text=fMRI Data Acquisition and Preprocessing The subjects underwent resting-state scans in a 3-T SIEMENS MRI scanner with the following parameters: 33 axial slices, repetition time = 2000 ms, echo time = 29 ms, flip angle = 75°, slice thickness = 3.5 mm, slice gap = 1.05 mm, acquisition matrix = 64 × 64, field of view = 240 mm.
23-1	4211-4215	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
23-2	4216-4220	Data	_
23-3	4221-4232	Acquisition	_
23-4	4233-4236	and	_
23-5	4237-4250	Preprocessing	_
23-6	4251-4254	The	_
23-7	4255-4263	subjects	_
23-8	4264-4273	underwent	_
23-9	4274-4287	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
23-10	4288-4293	scans	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
23-11	4294-4296	in	_
23-12	4297-4298	a	_
23-13	4299-4302	3-T	http://maven.renci.org/NeuroBridge/neurobridge#2Level
23-14	4303-4310	SIEMENS	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
23-15	4311-4314	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
23-16	4315-4322	scanner	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
23-17	4323-4327	with	_
23-18	4328-4331	the	_
23-19	4332-4341	following	_
23-20	4342-4352	parameters	_
23-21	4353-4354	:	_
23-22	4355-4357	33	_
23-23	4358-4363	axial	_
23-24	4364-4370	slices	_
23-25	4371-4372	,	_
23-26	4373-4383	repetition	_
23-27	4384-4388	time	_
23-28	4389-4390	=	_
23-29	4391-4395	2000	_
23-30	4396-4398	ms	_
23-31	4399-4400	,	_
23-32	4401-4405	echo	_
23-33	4406-4410	time	_
23-34	4411-4412	=	_
23-35	4413-4415	29	_
23-36	4416-4418	ms	_
23-37	4419-4420	,	_
23-38	4421-4425	flip	_
23-39	4426-4431	angle	_
23-40	4432-4433	=	_
23-41	4434-4437	75°	_
23-42	4438-4439	,	_
23-43	4440-4445	slice	_
23-44	4446-4455	thickness	_
23-45	4456-4457	=	_
23-46	4458-4461	3.5	_
23-47	4462-4464	mm	_
23-48	4465-4466	,	_
23-49	4467-4472	slice	_
23-50	4473-4476	gap	_
23-51	4477-4478	=	_
23-52	4479-4483	1.05	_
23-53	4484-4486	mm	_
23-54	4487-4488	,	_
23-55	4489-4500	acquisition	_
23-56	4501-4507	matrix	_
23-57	4508-4509	=	_
23-58	4510-4512	64	_
23-59	4513-4514	×	_
23-60	4515-4517	64	_
23-61	4518-4519	,	_
23-62	4520-4525	field	_
23-63	4526-4528	of	_
23-64	4529-4533	view	_
23-65	4534-4535	=	_
23-66	4536-4539	240	_
23-67	4540-4542	mm	_
23-68	4543-4544	.	_

Text=The total scan lasted 5 min, and 150 volumes of functional images were obtained.
24-1	4545-4548	The	_
24-2	4549-4554	total	_
24-3	4555-4559	scan	_
24-4	4560-4566	lasted	_
24-5	4567-4568	5	_
24-6	4569-4572	min	_
24-7	4573-4574	,	_
24-8	4575-4578	and	_
24-9	4579-4582	150	_
24-10	4583-4590	volumes	_
24-11	4591-4593	of	_
24-12	4594-4604	functional	_
24-13	4605-4611	images	_
24-14	4612-4616	were	_
24-15	4617-4625	obtained	_
24-16	4626-4627	.	_

Text=More information about the data acquisition can be found at http: //coins.mrn.org/dx.
25-1	4628-4632	More	_
25-2	4633-4644	information	_
25-3	4645-4650	about	_
25-4	4651-4654	the	_
25-5	4655-4659	data	_
25-6	4660-4671	acquisition	_
25-7	4672-4675	can	_
25-8	4676-4678	be	_
25-9	4679-4684	found	_
25-10	4685-4687	at	_
25-11	4688-4692	http	_
25-12	4693-4694	:	_
25-13	4695-4713	//coins.mrn.org/dx	_
25-14	4714-4715	.	_

Text=Data preprocessing was performed using SPM8 software (Wellcome Department of Imaging Neuroscience, University College London, UK; http: //www.fil.ion.ucl.ac.uk/spm).
26-1	4716-4720	Data	_
26-2	4721-4734	preprocessing	_
26-3	4735-4738	was	_
26-4	4739-4748	performed	_
26-5	4749-4754	using	_
26-6	4755-4759	SPM8	_
26-7	4760-4768	software	_
26-8	4769-4770	(	_
26-9	4771-4779	Wellcome	_
26-10	4780-4790	Department	_
26-11	4791-4793	of	_
26-12	4794-4801	Imaging	_
26-13	4802-4814	Neuroscience	_
26-14	4815-4816	,	_
26-15	4817-4827	University	_
26-16	4828-4835	College	_
26-17	4836-4842	London	_
26-18	4843-4844	,	_
26-19	4845-4847	UK	_
26-20	4848-4849	;	_
26-21	4850-4854	http	_
26-22	4855-4856	:	_
26-23	4857-4884	//www.fil.ion.ucl.ac.uk/spm	_
26-24	4885-4886	)	_
26-25	4887-4888	.	_

Text=Prior to preprocessing, the first 5 volumes of each scan were discarded due to magnetic saturation.
27-1	4889-4894	Prior	_
27-2	4895-4897	to	_
27-3	4898-4911	preprocessing	_
27-4	4912-4913	,	_
27-5	4914-4917	the	_
27-6	4918-4923	first	_
27-7	4924-4925	5	_
27-8	4926-4933	volumes	_
27-9	4934-4936	of	_
27-10	4937-4941	each	_
27-11	4942-4946	scan	_
27-12	4947-4951	were	_
27-13	4952-4961	discarded	_
27-14	4962-4965	due	_
27-15	4966-4968	to	_
27-16	4969-4977	magnetic	_
27-17	4978-4988	saturation	_
27-18	4989-4990	.	_

Text=Images were normalized to the standard EPI template in the MNI space and were resliced to 3 × 3 × 3 mm3.
28-1	4991-4997	Images	_
28-2	4998-5002	were	_
28-3	5003-5013	normalized	_
28-4	5014-5016	to	_
28-5	5017-5020	the	_
28-6	5021-5029	standard	_
28-7	5030-5033	EPI	_
28-8	5034-5042	template	_
28-9	5043-5045	in	_
28-10	5046-5049	the	_
28-11	5050-5053	MNI	_
28-12	5054-5059	space	_
28-13	5060-5063	and	_
28-14	5064-5068	were	_
28-15	5069-5077	resliced	_
28-16	5078-5080	to	_
28-17	5081-5082	3	_
28-18	5083-5084	×	_
28-19	5085-5086	3	_
28-20	5087-5088	×	_
28-21	5089-5090	3	_
28-22	5091-5094	mm3	_
28-23	5095-5096	.	_

Text=The resulting images were spatially smoothed with a Gaussian filter of 6 mm full-width half-maximum kernel.
29-1	5097-5100	The	_
29-2	5101-5110	resulting	_
29-3	5111-5117	images	_
29-4	5118-5122	were	_
29-5	5123-5132	spatially	_
29-6	5133-5141	smoothed	_
29-7	5142-5146	with	_
29-8	5147-5148	a	_
29-9	5149-5157	Gaussian	_
29-10	5158-5164	filter	_
29-11	5165-5167	of	_
29-12	5168-5169	6	_
29-13	5170-5172	mm	_
29-14	5173-5183	full-width	_
29-15	5184-5196	half-maximum	_
29-16	5197-5203	kernel	_
29-17	5204-5205	.	_

Text=For functional connectivity analyses, several additional de-noising steps were conducted to reduce spurious variance that was unlikely to reflect neuronal activity.
30-1	5206-5209	For	_
30-2	5210-5220	functional	_
30-3	5221-5233	connectivity	_
30-4	5234-5242	analyses	_
30-5	5243-5244	,	_
30-6	5245-5252	several	_
30-7	5253-5263	additional	_
30-8	5264-5274	de-noising	_
30-9	5275-5280	steps	_
30-10	5281-5285	were	_
30-11	5286-5295	conducted	_
30-12	5296-5298	to	_
30-13	5299-5305	reduce	_
30-14	5306-5314	spurious	_
30-15	5315-5323	variance	_
30-16	5324-5328	that	_
30-17	5329-5332	was	_
30-18	5333-5341	unlikely	_
30-19	5342-5344	to	_
30-20	5345-5352	reflect	_
30-21	5353-5361	neuronal	_
30-22	5362-5370	activity	_
30-23	5371-5372	.	_

Text=These steps included: (1) removal of nuisance signals from the data via multiple regression, including signals averaged from white matter, cerebrospinal fluid, and the whole brain, and the six parameters obtained by head motion correction, (2) temporal filtering with a band-pass filter (0.01–0.1 Hz), and (3) linear detrending to remove any residual drift.
31-1	5373-5378	These	_
31-2	5379-5384	steps	_
31-3	5385-5393	included	_
31-4	5394-5395	:	_
31-5	5396-5397	(	_
31-6	5398-5399	1	_
31-7	5400-5401	)	_
31-8	5402-5409	removal	_
31-9	5410-5412	of	_
31-10	5413-5421	nuisance	_
31-11	5422-5429	signals	_
31-12	5430-5434	from	_
31-13	5435-5438	the	_
31-14	5439-5443	data	_
31-15	5444-5447	via	_
31-16	5448-5456	multiple	_
31-17	5457-5467	regression	_
31-18	5468-5469	,	_
31-19	5470-5479	including	_
31-20	5480-5487	signals	_
31-21	5488-5496	averaged	_
31-22	5497-5501	from	_
31-23	5502-5507	white	_
31-24	5508-5514	matter	_
31-25	5515-5516	,	_
31-26	5517-5530	cerebrospinal	_
31-27	5531-5536	fluid	_
31-28	5537-5538	,	_
31-29	5539-5542	and	_
31-30	5543-5546	the	_
31-31	5547-5552	whole	_
31-32	5553-5558	brain	_
31-33	5559-5560	,	_
31-34	5561-5564	and	_
31-35	5565-5568	the	_
31-36	5569-5572	six	_
31-37	5573-5583	parameters	_
31-38	5584-5592	obtained	_
31-39	5593-5595	by	_
31-40	5596-5600	head	_
31-41	5601-5607	motion	_
31-42	5608-5618	correction	_
31-43	5619-5620	,	_
31-44	5621-5622	(	_
31-45	5623-5624	2	_
31-46	5625-5626	)	_
31-47	5627-5635	temporal	_
31-48	5636-5645	filtering	_
31-49	5646-5650	with	_
31-50	5651-5652	a	_
31-51	5653-5662	band-pass	_
31-52	5663-5669	filter	_
31-53	5670-5671	(	_
31-54	5672-5680	0.01–0.1	_
31-55	5681-5683	Hz	_
31-56	5684-5685	)	_
31-57	5686-5687	,	_
31-58	5688-5691	and	_
31-59	5692-5693	(	_
31-60	5694-5695	3	_
31-61	5696-5697	)	_
31-62	5698-5704	linear	_
31-63	5705-5715	detrending	_
31-64	5716-5718	to	_
31-65	5719-5725	remove	_
31-66	5726-5729	any	_
31-67	5730-5738	residual	_
31-68	5739-5744	drift	_
31-69	5745-5746	.	_

Text=Head motion has been increasingly found to be a serious factor that confounds estimation of functional connectivity.
32-1	5747-5751	Head	_
32-2	5752-5758	motion	_
32-3	5759-5762	has	_
32-4	5763-5767	been	_
32-5	5768-5780	increasingly	_
32-6	5781-5786	found	_
32-7	5787-5789	to	_
32-8	5790-5792	be	_
32-9	5793-5794	a	_
32-10	5795-5802	serious	_
32-11	5803-5809	factor	_
32-12	5810-5814	that	_
32-13	5815-5824	confounds	_
32-14	5825-5835	estimation	_
32-15	5836-5838	of	_
32-16	5839-5849	functional	_
32-17	5850-5862	connectivity	_
32-18	5863-5864	.	_

Text=Here, we used the artifact detection tool (ART; http: //www.nitrc.org/projects/artifact_detect) to identify motion outliers.
33-1	5865-5869	Here	_
33-2	5870-5871	,	_
33-3	5872-5874	we	_
33-4	5875-5879	used	_
33-5	5880-5883	the	_
33-6	5884-5892	artifact	_
33-7	5893-5902	detection	_
33-8	5903-5907	tool	_
33-9	5908-5909	(	_
33-10	5910-5913	ART	_
33-11	5914-5915	;	_
33-12	5916-5920	http	_
33-13	5921-5922	:	_
33-14	5923-5963	//www.nitrc.org/projects/artifact_detect	_
33-15	5964-5965	)	_
33-16	5966-5968	to	_
33-17	5969-5977	identify	_
33-18	5978-5984	motion	_
33-19	5985-5993	outliers	_
33-20	5994-5995	.	_

Text=An image was defined as an outlier if the absolute head motion was> 1 mm from previous scan, or if the scan-to-scan global signal change was> 3 standard deviations of the global brain signal for the entire resting scan.
34-1	5996-5998	An	_
34-2	5999-6004	image	_
34-3	6005-6008	was	_
34-4	6009-6016	defined	_
34-5	6017-6019	as	_
34-6	6020-6022	an	_
34-7	6023-6030	outlier	_
34-8	6031-6033	if	_
34-9	6034-6037	the	_
34-10	6038-6046	absolute	_
34-11	6047-6051	head	_
34-12	6052-6058	motion	_
34-13	6059-6062	was	_
34-14	6063-6064	>	_
34-15	6065-6066	1	_
34-16	6067-6069	mm	_
34-17	6070-6074	from	_
34-18	6075-6083	previous	_
34-19	6084-6088	scan	_
34-20	6089-6090	,	_
34-21	6091-6093	or	_
34-22	6094-6096	if	_
34-23	6097-6100	the	_
34-24	6101-6113	scan-to-scan	_
34-25	6114-6120	global	_
34-26	6121-6127	signal	_
34-27	6128-6134	change	_
34-28	6135-6138	was	_
34-29	6139-6140	>	_
34-30	6141-6142	3	_
34-31	6143-6151	standard	_
34-32	6152-6162	deviations	_
34-33	6163-6165	of	_
34-34	6166-6169	the	_
34-35	6170-6176	global	_
34-36	6177-6182	brain	_
34-37	6183-6189	signal	_
34-38	6190-6193	for	_
34-39	6194-6197	the	_
34-40	6198-6204	entire	_
34-41	6205-6212	resting	_
34-42	6213-6217	scan	_
34-43	6218-6219	.	_

Text=Subjects with serious head motion (> 20% outlier volumes) were excluded from this study, leaving a final sample of 72 healthy subjects and 59 schizophrenia patients.
35-1	6220-6228	Subjects	_
35-2	6229-6233	with	_
35-3	6234-6241	serious	_
35-4	6242-6246	head	_
35-5	6247-6253	motion	_
35-6	6254-6255	(	_
35-7	6256-6257	>	_
35-8	6258-6260	20	_
35-9	6261-6262	%	_
35-10	6263-6270	outlier	_
35-11	6271-6278	volumes	_
35-12	6279-6280	)	_
35-13	6281-6285	were	_
35-14	6286-6294	excluded	_
35-15	6295-6299	from	_
35-16	6300-6304	this	_
35-17	6305-6310	study	_
35-18	6311-6312	,	_
35-19	6313-6320	leaving	_
35-20	6321-6322	a	_
35-21	6323-6328	final	_
35-22	6329-6335	sample	_
35-23	6336-6338	of	_
35-24	6339-6341	72	_
35-25	6342-6349	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
35-26	6350-6358	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
35-27	6359-6362	and	_
35-28	6363-6365	59	_
35-29	6366-6379	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
35-30	6380-6388	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
35-31	6389-6390	.	_

Text=Outliers in the global mean signal intensity and motion were scrubbed by including them as nuisance regressors (i.e.
36-1	6391-6399	Outliers	_
36-2	6400-6402	in	_
36-3	6403-6406	the	_
36-4	6407-6413	global	_
36-5	6414-6418	mean	_
36-6	6419-6425	signal	_
36-7	6426-6435	intensity	_
36-8	6436-6439	and	_
36-9	6440-6446	motion	_
36-10	6447-6451	were	_
36-11	6452-6460	scrubbed	_
36-12	6461-6463	by	_
36-13	6464-6473	including	_
36-14	6474-6478	them	_
36-15	6479-6481	as	_
36-16	6482-6490	nuisance	_
36-17	6491-6501	regressors	_
36-18	6502-6503	(	_
36-19	6504-6507	i.e	_
36-20	6508-6509	.	_

Text=one regressor per outlier) during the de-noising procedure.
37-1	6510-6513	one	_
37-2	6514-6523	regressor	_
37-3	6524-6527	per	_
37-4	6528-6535	outlier	_
37-5	6536-6537	)	_
37-6	6538-6544	during	_
37-7	6545-6548	the	_
37-8	6549-6559	de-noising	_
37-9	6560-6569	procedure	_
37-10	6570-6571	.	_

Text=After scrubbing, residual head motion was still significantly different between groups (control: 0.25 ± 0.11 mm; patient: 0.30 ± 0.13 mm; two-sample t-test, p = 0.024).
38-1	6572-6577	After	_
38-2	6578-6587	scrubbing	_
38-3	6588-6589	,	_
38-4	6590-6598	residual	_
38-5	6599-6603	head	_
38-6	6604-6610	motion	_
38-7	6611-6614	was	_
38-8	6615-6620	still	_
38-9	6621-6634	significantly	_
38-10	6635-6644	different	_
38-11	6645-6652	between	_
38-12	6653-6659	groups	_
38-13	6660-6661	(	_
38-14	6662-6669	control	_
38-15	6670-6671	:	_
38-16	6672-6676	0.25	_
38-17	6677-6678	±	_
38-18	6679-6683	0.11	_
38-19	6684-6686	mm	_
38-20	6687-6688	;	_
38-21	6689-6696	patient	_
38-22	6697-6698	:	_
38-23	6699-6703	0.30	_
38-24	6704-6705	±	_
38-25	6706-6710	0.13	_
38-26	6711-6713	mm	_
38-27	6714-6715	;	_
38-28	6716-6726	two-sample	_
38-29	6727-6733	t-test	_
38-30	6734-6735	,	_
38-31	6736-6737	p	_
38-32	6738-6739	=	_
38-33	6740-6745	0.024	_
38-34	6746-6747	)	_
38-35	6748-6749	.	_

Text=To minimize potential bias caused by subtle motion, residual head motion was included as a nuisance covariate in the statistical comparisons.
39-1	6750-6752	To	_
39-2	6753-6761	minimize	_
39-3	6762-6771	potential	_
39-4	6772-6776	bias	_
39-5	6777-6783	caused	_
39-6	6784-6786	by	_
39-7	6787-6793	subtle	_
39-8	6794-6800	motion	_
39-9	6801-6802	,	_
39-10	6803-6811	residual	_
39-11	6812-6816	head	_
39-12	6817-6823	motion	_
39-13	6824-6827	was	_
39-14	6828-6836	included	_
39-15	6837-6839	as	_
39-16	6840-6841	a	_
39-17	6842-6850	nuisance	_
39-18	6851-6860	covariate	_
39-19	6861-6863	in	_
39-20	6864-6867	the	_
39-21	6868-6879	statistical	_
39-22	6880-6891	comparisons	_
39-23	6892-6893	.	_

Text=Functional connectivity analysis First, we compared functional connectivity between anatomically defined cortical ROIs and functionally defined thalamic ROIs across groups.
40-1	6894-6904	Functional	_
40-2	6905-6917	connectivity	_
40-3	6918-6926	analysis	_
40-4	6927-6932	First	_
40-5	6933-6934	,	_
40-6	6935-6937	we	_
40-7	6938-6946	compared	_
40-8	6947-6957	functional	_
40-9	6958-6970	connectivity	_
40-10	6971-6978	between	_
40-11	6979-6991	anatomically	_
40-12	6992-6999	defined	_
40-13	7000-7008	cortical	_
40-14	7009-7013	ROIs	_
40-15	7014-7017	and	_
40-16	7018-7030	functionally	_
40-17	7031-7038	defined	_
40-18	7039-7047	thalamic	_
40-19	7048-7052	ROIs	_
40-20	7053-7059	across	_
40-21	7060-7066	groups	_
40-22	7067-7068	.	_

Text=As described previously, the cortex was divided into six non-overlapping ROIs corresponding to the main targets of specific thalamic nuclei (the PFC, motor cortex, somatosensory cortex, posterior parietal cortex, temporal lobe and occipital lobe).
41-1	7069-7071	As	_
41-2	7072-7081	described	_
41-3	7082-7092	previously	_
41-4	7093-7094	,	_
41-5	7095-7098	the	_
41-6	7099-7105	cortex	_
41-7	7106-7109	was	_
41-8	7110-7117	divided	_
41-9	7118-7122	into	_
41-10	7123-7126	six	_
41-11	7127-7142	non-overlapping	_
41-12	7143-7147	ROIs	_
41-13	7148-7161	corresponding	_
41-14	7162-7164	to	_
41-15	7165-7168	the	_
41-16	7169-7173	main	_
41-17	7174-7181	targets	_
41-18	7182-7184	of	_
41-19	7185-7193	specific	_
41-20	7194-7202	thalamic	_
41-21	7203-7209	nuclei	_
41-22	7210-7211	(	_
41-23	7212-7215	the	_
41-24	7216-7219	PFC	_
41-25	7220-7221	,	_
41-26	7222-7227	motor	_
41-27	7228-7234	cortex	_
41-28	7235-7236	,	_
41-29	7237-7250	somatosensory	_
41-30	7251-7257	cortex	_
41-31	7258-7259	,	_
41-32	7260-7269	posterior	_
41-33	7270-7278	parietal	_
41-34	7279-7285	cortex	_
41-35	7286-7287	,	_
41-36	7288-7296	temporal	_
41-37	7297-7301	lobe	_
41-38	7302-7305	and	_
41-39	7306-7315	occipital	_
41-40	7316-7320	lobe	_
41-41	7321-7322	)	_
41-42	7323-7324	.	_

Text=The cortical ROI and thalamus masks were separately defined in standard MNI space by using the Harvard-Oxford cortical and subcortical probabilistic atlases in FSL (http: //fsl.fmrib.ox.ac.uk/fsl/fslwiki/Atlases).
42-1	7325-7328	The	_
42-2	7329-7337	cortical	_
42-3	7338-7341	ROI	_
42-4	7342-7345	and	_
42-5	7346-7354	thalamus	_
42-6	7355-7360	masks	_
42-7	7361-7365	were	_
42-8	7366-7376	separately	_
42-9	7377-7384	defined	_
42-10	7385-7387	in	_
42-11	7388-7396	standard	_
42-12	7397-7400	MNI	_
42-13	7401-7406	space	_
42-14	7407-7409	by	_
42-15	7410-7415	using	_
42-16	7416-7419	the	_
42-17	7420-7434	Harvard-Oxford	_
42-18	7435-7443	cortical	_
42-19	7444-7447	and	_
42-20	7448-7459	subcortical	_
42-21	7460-7473	probabilistic	_
42-22	7474-7481	atlases	_
42-23	7482-7484	in	_
42-24	7485-7488	FSL	_
42-25	7489-7490	(	_
42-26	7491-7495	http	_
42-27	7496-7497	:	_
42-28	7498-7538	//fsl.fmrib.ox.ac.uk/fsl/fslwiki/Atlases	_
42-29	7539-7540	)	_
42-30	7541-7542	.	_

Text=A 25% threshold was applied to these atlases to avoid partial inclusion of neighboring ventricles.
43-1	7543-7544	A	_
43-2	7545-7547	25	_
43-3	7548-7549	%	_
43-4	7550-7559	threshold	_
43-5	7560-7563	was	_
43-6	7564-7571	applied	_
43-7	7572-7574	to	_
43-8	7575-7580	these	_
43-9	7581-7588	atlases	_
43-10	7589-7591	to	_
43-11	7592-7597	avoid	_
43-12	7598-7605	partial	_
43-13	7606-7615	inclusion	_
43-14	7616-7618	of	_
43-15	7619-7630	neighboring	_
43-16	7631-7641	ventricles	_
43-17	7642-7643	.	_

Text=Figure 2A shows the six cortical ROI masks, which are equivalent to those used in Woodward et al ..
44-1	7644-7650	Figure	_
44-2	7651-7653	2A	_
44-3	7654-7659	shows	_
44-4	7660-7663	the	_
44-5	7664-7667	six	_
44-6	7668-7676	cortical	_
44-7	7677-7680	ROI	_
44-8	7681-7686	masks	_
44-9	7687-7688	,	_
44-10	7689-7694	which	_
44-11	7695-7698	are	_
44-12	7699-7709	equivalent	_
44-13	7710-7712	to	_
44-14	7713-7718	those	_
44-15	7719-7723	used	_
44-16	7724-7726	in	_
44-17	7727-7735	Woodward	_
44-18	7736-7738	et	_
44-19	7739-7741	al	_
44-20	7742-7744	..	_

Text=The Pearson ’ s correlation coefficient was then computed between the average BOLD signals from each of the cortical ROIs and BOLD signals from every voxel in the thalamus.
45-1	7745-7748	The	_
45-2	7749-7756	Pearson	_
45-3	7757-7758	’	_
45-4	7759-7760	s	_
45-5	7761-7772	correlation	_
45-6	7773-7784	coefficient	_
45-7	7785-7788	was	_
45-8	7789-7793	then	_
45-9	7794-7802	computed	_
45-10	7803-7810	between	_
45-11	7811-7814	the	_
45-12	7815-7822	average	_
45-13	7823-7827	BOLD	_
45-14	7828-7835	signals	_
45-15	7836-7840	from	_
45-16	7841-7845	each	_
45-17	7846-7848	of	_
45-18	7849-7852	the	_
45-19	7853-7861	cortical	_
45-20	7862-7866	ROIs	_
45-21	7867-7870	and	_
45-22	7871-7875	BOLD	_
45-23	7876-7883	signals	_
45-24	7884-7888	from	_
45-25	7889-7894	every	_
45-26	7895-7900	voxel	_
45-27	7901-7903	in	_
45-28	7904-7907	the	_
45-29	7908-7916	thalamus	_
45-30	7917-7918	.	_

Text=Fisher ’ s z-transformation was applied to the correlation values to ensure normality.
46-1	7919-7925	Fisher	_
46-2	7926-7927	’	_
46-3	7928-7929	s	_
46-4	7930-7946	z-transformation	_
46-5	7947-7950	was	_
46-6	7951-7958	applied	_
46-7	7959-7961	to	_
46-8	7962-7965	the	_
46-9	7966-7977	correlation	_
46-10	7978-7984	values	_
46-11	7985-7987	to	_
46-12	7988-7994	ensure	_
46-13	7995-8004	normality	_
46-14	8005-8006	.	_

Text=Based on the entire dataset of 131 subjects, functional thalamic subdivision was created using the winner-takes-all strategy, in which each thalamic voxel was labeled according to the cortical ROI with the highest connectivity strength.
47-1	8007-8012	Based	_
47-2	8013-8015	on	_
47-3	8016-8019	the	_
47-4	8020-8026	entire	_
47-5	8027-8034	dataset	_
47-6	8035-8037	of	_
47-7	8038-8041	131	_
47-8	8042-8050	subjects	_
47-9	8051-8052	,	_
47-10	8053-8063	functional	_
47-11	8064-8072	thalamic	_
47-12	8073-8084	subdivision	_
47-13	8085-8088	was	_
47-14	8089-8096	created	_
47-15	8097-8102	using	_
47-16	8103-8106	the	_
47-17	8107-8123	winner-takes-all	_
47-18	8124-8132	strategy	_
47-19	8133-8134	,	_
47-20	8135-8137	in	_
47-21	8138-8143	which	_
47-22	8144-8148	each	_
47-23	8149-8157	thalamic	_
47-24	8158-8163	voxel	_
47-25	8164-8167	was	_
47-26	8168-8175	labeled	_
47-27	8176-8185	according	_
47-28	8186-8188	to	_
47-29	8189-8192	the	_
47-30	8193-8201	cortical	_
47-31	8202-8205	ROI	_
47-32	8206-8210	with	_
47-33	8211-8214	the	_
47-34	8215-8222	highest	_
47-35	8223-8235	connectivity	_
47-36	8236-8244	strength	_
47-37	8245-8246	.	_

Text=For each participant, six thalamocortical network values were calculated by averaging connectivity strength of the voxels within each thalamic functional ROI with its respective cortical ROI, which served as the dependent variable in the cortical ROI-to-thalamic ROI analysis.
48-1	8247-8250	For	_
48-2	8251-8255	each	_
48-3	8256-8267	participant	_
48-4	8268-8269	,	_
48-5	8270-8273	six	_
48-6	8274-8289	thalamocortical	_
48-7	8290-8297	network	_
48-8	8298-8304	values	_
48-9	8305-8309	were	_
48-10	8310-8320	calculated	_
48-11	8321-8323	by	_
48-12	8324-8333	averaging	_
48-13	8334-8346	connectivity	_
48-14	8347-8355	strength	_
48-15	8356-8358	of	_
48-16	8359-8362	the	_
48-17	8363-8369	voxels	_
48-18	8370-8376	within	_
48-19	8377-8381	each	_
48-20	8382-8390	thalamic	_
48-21	8391-8401	functional	_
48-22	8402-8405	ROI	_
48-23	8406-8410	with	_
48-24	8411-8414	its	_
48-25	8415-8425	respective	_
48-26	8426-8434	cortical	_
48-27	8435-8438	ROI	_
48-28	8439-8440	,	_
48-29	8441-8446	which	_
48-30	8447-8453	served	_
48-31	8454-8456	as	_
48-32	8457-8460	the	_
48-33	8461-8470	dependent	_
48-34	8471-8479	variable	_
48-35	8480-8482	in	_
48-36	8483-8486	the	_
48-37	8487-8495	cortical	_
48-38	8496-8511	ROI-to-thalamic	_
48-39	8512-8515	ROI	_
48-40	8516-8524	analysis	_
48-41	8525-8526	.	_

Text=Second, seed-based analyses examining connectivity of functionally defined thalamic subregions with the rest of the brain were performed to better localize thalamocortical network abnormalities in patients with schizophrenia.
49-1	8527-8533	Second	_
49-2	8534-8535	,	_
49-3	8536-8546	seed-based	_
49-4	8547-8555	analyses	_
49-5	8556-8565	examining	_
49-6	8566-8578	connectivity	_
49-7	8579-8581	of	_
49-8	8582-8594	functionally	_
49-9	8595-8602	defined	_
49-10	8603-8611	thalamic	_
49-11	8612-8622	subregions	_
49-12	8623-8627	with	_
49-13	8628-8631	the	_
49-14	8632-8636	rest	_
49-15	8637-8639	of	_
49-16	8640-8643	the	_
49-17	8644-8649	brain	_
49-18	8650-8654	were	_
49-19	8655-8664	performed	_
49-20	8665-8667	to	_
49-21	8668-8674	better	_
49-22	8675-8683	localize	_
49-23	8684-8699	thalamocortical	_
49-24	8700-8707	network	_
49-25	8708-8721	abnormalities	_
49-26	8722-8724	in	_
49-27	8725-8733	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
49-28	8734-8738	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
49-29	8739-8752	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
49-30	8753-8754	.	_

Text=Briefly, for each subject and for each thalamic ROI, the correlation map was created by calculating the Pearson ’ s correlation coefficients between the average BOLD signal of the thalamus ROI and BOLD signals of all voxels in the brain.
50-1	8755-8762	Briefly	_
50-2	8763-8764	,	_
50-3	8765-8768	for	_
50-4	8769-8773	each	_
50-5	8774-8781	subject	_
50-6	8782-8785	and	_
50-7	8786-8789	for	_
50-8	8790-8794	each	_
50-9	8795-8803	thalamic	_
50-10	8804-8807	ROI	_
50-11	8808-8809	,	_
50-12	8810-8813	the	_
50-13	8814-8825	correlation	_
50-14	8826-8829	map	_
50-15	8830-8833	was	_
50-16	8834-8841	created	_
50-17	8842-8844	by	_
50-18	8845-8856	calculating	_
50-19	8857-8860	the	_
50-20	8861-8868	Pearson	_
50-21	8869-8870	’	_
50-22	8871-8872	s	_
50-23	8873-8884	correlation	_
50-24	8885-8897	coefficients	_
50-25	8898-8905	between	_
50-26	8906-8909	the	_
50-27	8910-8917	average	_
50-28	8918-8922	BOLD	_
50-29	8923-8929	signal	_
50-30	8930-8932	of	_
50-31	8933-8936	the	_
50-32	8937-8945	thalamus	_
50-33	8946-8949	ROI	_
50-34	8950-8953	and	_
50-35	8954-8958	BOLD	_
50-36	8959-8966	signals	_
50-37	8967-8969	of	_
50-38	8970-8973	all	_
50-39	8974-8980	voxels	_
50-40	8981-8983	in	_
50-41	8984-8987	the	_
50-42	8988-8993	brain	_
50-43	8994-8995	.	_

Text=These correlation maps were then converted to Z-value maps using Fisher ’ s r-to-z transformation.
51-1	8996-9001	These	_
51-2	9002-9013	correlation	_
51-3	9014-9018	maps	_
51-4	9019-9023	were	_
51-5	9024-9028	then	_
51-6	9029-9038	converted	_
51-7	9039-9041	to	_
51-8	9042-9049	Z-value	_
51-9	9050-9054	maps	_
51-10	9055-9060	using	_
51-11	9061-9067	Fisher	_
51-12	9068-9069	’	_
51-13	9070-9071	s	_
51-14	9072-9078	r-to-z	_
51-15	9079-9093	transformation	_
51-16	9094-9095	.	_

Text=Statistical analysis Behavioral data and cortical ROI-to-thalamic ROI functional connectivity data were compared between the control and schizophrenia groups using SPSS (version 20, IBM Inc, USA).
52-1	9096-9107	Statistical	_
52-2	9108-9116	analysis	_
52-3	9117-9127	Behavioral	_
52-4	9128-9132	data	_
52-5	9133-9136	and	_
52-6	9137-9145	cortical	_
52-7	9146-9161	ROI-to-thalamic	_
52-8	9162-9165	ROI	_
52-9	9166-9176	functional	_
52-10	9177-9189	connectivity	_
52-11	9190-9194	data	_
52-12	9195-9199	were	_
52-13	9200-9208	compared	_
52-14	9209-9216	between	_
52-15	9217-9220	the	_
52-16	9221-9228	control	_
52-17	9229-9232	and	_
52-18	9233-9246	schizophrenia	_
52-19	9247-9253	groups	_
52-20	9254-9259	using	_
52-21	9260-9264	SPSS	_
52-22	9265-9266	(	_
52-23	9267-9274	version	_
52-24	9275-9277	20	_
52-25	9278-9279	,	_
52-26	9280-9283	IBM	_
52-27	9284-9287	Inc	_
52-28	9288-9289	,	_
52-29	9290-9293	USA	_
52-30	9294-9295	)	_
52-31	9296-9297	.	_

Text=To reduce the number of false positive or Type I error, the results were considered significant at p <0.05, Bonferroni corrected for multiple comparisons replaced the nominal significance level α with the level α/k for each test (k is the number of tests being performed).
53-1	9298-9300	To	_
53-2	9301-9307	reduce	_
53-3	9308-9311	the	_
53-4	9312-9318	number	_
53-5	9319-9321	of	_
53-6	9322-9327	false	_
53-7	9328-9336	positive	_
53-8	9337-9339	or	_
53-9	9340-9344	Type	_
53-10	9345-9346	I	_
53-11	9347-9352	error	_
53-12	9353-9354	,	_
53-13	9355-9358	the	_
53-14	9359-9366	results	_
53-15	9367-9371	were	_
53-16	9372-9382	considered	_
53-17	9383-9394	significant	_
53-18	9395-9397	at	_
53-19	9398-9399	p	_
53-20	9400-9401	<	_
53-21	9402-9406	0.05	_
53-22	9407-9408	,	_
53-23	9409-9419	Bonferroni	_
53-24	9420-9429	corrected	_
53-25	9430-9433	for	_
53-26	9434-9442	multiple	_
53-27	9443-9454	comparisons	_
53-28	9455-9463	replaced	_
53-29	9464-9467	the	_
53-30	9468-9475	nominal	_
53-31	9476-9488	significance	_
53-32	9489-9494	level	_
53-33	9495-9496	α	_
53-34	9497-9501	with	_
53-35	9502-9505	the	_
53-36	9506-9511	level	_
53-37	9512-9515	α/k	_
53-38	9516-9519	for	_
53-39	9520-9524	each	_
53-40	9525-9529	test	_
53-41	9530-9531	(	_
53-42	9532-9533	k	_
53-43	9534-9536	is	_
53-44	9537-9540	the	_
53-45	9541-9547	number	_
53-46	9548-9550	of	_
53-47	9551-9556	tests	_
53-48	9557-9562	being	_
53-49	9563-9572	performed	_
53-50	9573-9574	)	_
53-51	9575-9576	.	_

Text=Voxel-wise statistical analyses were carried out using the general linear model in SPM8.
54-1	9577-9587	Voxel-wise	_
54-2	9588-9599	statistical	_
54-3	9600-9608	analyses	_
54-4	9609-9613	were	_
54-5	9614-9621	carried	_
54-6	9622-9625	out	_
54-7	9626-9631	using	_
54-8	9632-9635	the	_
54-9	9636-9643	general	_
54-10	9644-9650	linear	_
54-11	9651-9656	model	_
54-12	9657-9659	in	_
54-13	9660-9664	SPM8	_
54-14	9665-9666	.	_

Text=First, correlation maps of control and schizophrenia subjects separately underwent a two-tailed, one-sample t-test, to determine brain regions with significant positive or negative correlations with each thalamic ROI.
55-1	9667-9672	First	_
55-2	9673-9674	,	_
55-3	9675-9686	correlation	_
55-4	9687-9691	maps	_
55-5	9692-9694	of	_
55-6	9695-9702	control	_
55-7	9703-9706	and	_
55-8	9707-9720	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
55-9	9721-9729	subjects	_
55-10	9730-9740	separately	_
55-11	9741-9750	underwent	_
55-12	9751-9752	a	_
55-13	9753-9763	two-tailed	_
55-14	9764-9765	,	_
55-15	9766-9776	one-sample	_
55-16	9777-9783	t-test	_
55-17	9784-9785	,	_
55-18	9786-9788	to	_
55-19	9789-9798	determine	_
55-20	9799-9804	brain	_
55-21	9805-9812	regions	_
55-22	9813-9817	with	_
55-23	9818-9829	significant	_
55-24	9830-9838	positive	_
55-25	9839-9841	or	_
55-26	9842-9850	negative	_
55-27	9851-9863	correlations	_
55-28	9864-9868	with	_
55-29	9869-9873	each	_
55-30	9874-9882	thalamic	_
55-31	9883-9886	ROI	_
55-32	9887-9888	.	_

Text=Then, a two-tailed, two-sample t-test was conducted to identify significant functional connectivity differences in the correlation maps of each thalamic ROI between the schizophrenia and control groups.
56-1	9889-9893	Then	_
56-2	9894-9895	,	_
56-3	9896-9897	a	_
56-4	9898-9908	two-tailed	_
56-5	9909-9910	,	_
56-6	9911-9921	two-sample	_
56-7	9922-9928	t-test	_
56-8	9929-9932	was	_
56-9	9933-9942	conducted	_
56-10	9943-9945	to	_
56-11	9946-9954	identify	_
56-12	9955-9966	significant	_
56-13	9967-9977	functional	_
56-14	9978-9990	connectivity	_
56-15	9991-10002	differences	_
56-16	10003-10005	in	_
56-17	10006-10009	the	_
56-18	10010-10021	correlation	_
56-19	10022-10026	maps	_
56-20	10027-10029	of	_
56-21	10030-10034	each	_
56-22	10035-10043	thalamic	_
56-23	10044-10047	ROI	_
56-24	10048-10055	between	_
56-25	10056-10059	the	_
56-26	10060-10073	schizophrenia	_
56-27	10074-10077	and	_
56-28	10078-10085	control	_
56-29	10086-10092	groups	_
56-30	10093-10094	.	_

Text=The correlation analysis with the MATRICS domain scores across schizophrenia subjects was restricted to voxels within the masks, which were identified in the analysis between groups, to determine the association between thalamocortical functional connectivity abnormalities and cognitive deficits in schizophrenia.
57-1	10095-10098	The	_
57-2	10099-10110	correlation	_
57-3	10111-10119	analysis	_
57-4	10120-10124	with	_
57-5	10125-10128	the	_
57-6	10129-10136	MATRICS	_
57-7	10137-10143	domain	_
57-8	10144-10150	scores	_
57-9	10151-10157	across	_
57-10	10158-10171	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
57-11	10172-10180	subjects	_
57-12	10181-10184	was	_
57-13	10185-10195	restricted	_
57-14	10196-10198	to	_
57-15	10199-10205	voxels	_
57-16	10206-10212	within	_
57-17	10213-10216	the	_
57-18	10217-10222	masks	_
57-19	10223-10224	,	_
57-20	10225-10230	which	_
57-21	10231-10235	were	_
57-22	10236-10246	identified	_
57-23	10247-10249	in	_
57-24	10250-10253	the	_
57-25	10254-10262	analysis	_
57-26	10263-10270	between	_
57-27	10271-10277	groups	_
57-28	10278-10279	,	_
57-29	10280-10282	to	_
57-30	10283-10292	determine	_
57-31	10293-10296	the	_
57-32	10297-10308	association	_
57-33	10309-10316	between	_
57-34	10317-10332	thalamocortical	_
57-35	10333-10343	functional	_
57-36	10344-10356	connectivity	_
57-37	10357-10370	abnormalities	_
57-38	10371-10374	and	_
57-39	10375-10384	cognitive	_
57-40	10385-10393	deficits	_
57-41	10394-10396	in	_
57-42	10397-10410	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
57-43	10411-10412	.	_

Text=We also examined the correlations between thalamocortical functional connectivity and patients ’ symptoms, including PANSS positive, negative and general.
58-1	10413-10415	We	_
58-2	10416-10420	also	_
58-3	10421-10429	examined	_
58-4	10430-10433	the	_
58-5	10434-10446	correlations	_
58-6	10447-10454	between	_
58-7	10455-10470	thalamocortical	_
58-8	10471-10481	functional	_
58-9	10482-10494	connectivity	_
58-10	10495-10498	and	_
58-11	10499-10507	patients	_
58-12	10508-10509	’	_
58-13	10510-10518	symptoms	_
58-14	10519-10520	,	_
58-15	10521-10530	including	_
58-16	10531-10536	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale
58-17	10537-10545	positive	_
58-18	10546-10547	,	_
58-19	10548-10556	negative	_
58-20	10557-10560	and	_
58-21	10561-10568	general	_
58-22	10569-10570	.	_

Text=Each analysis was adjusted using nuisance covariates for age, sex and residual head motion.
59-1	10571-10575	Each	_
59-2	10576-10584	analysis	_
59-3	10585-10588	was	_
59-4	10589-10597	adjusted	_
59-5	10598-10603	using	_
59-6	10604-10612	nuisance	_
59-7	10613-10623	covariates	_
59-8	10624-10627	for	_
59-9	10628-10631	age	_
59-10	10632-10633	,	_
59-11	10634-10637	sex	_
59-12	10638-10641	and	_
59-13	10642-10650	residual	_
59-14	10651-10655	head	_
59-15	10656-10662	motion	_
59-16	10663-10664	.	_

Text=Duration of illness and CPZ equivalents were also used as nuisance covariates for the correlation analysis with cognition.
60-1	10665-10673	Duration	_
60-2	10674-10676	of	_
60-3	10677-10684	illness	_
60-4	10685-10688	and	_
60-5	10689-10692	CPZ	_
60-6	10693-10704	equivalents	_
60-7	10705-10709	were	_
60-8	10710-10714	also	_
60-9	10715-10719	used	_
60-10	10720-10722	as	_
60-11	10723-10731	nuisance	_
60-12	10732-10742	covariates	_
60-13	10743-10746	for	_
60-14	10747-10750	the	_
60-15	10751-10762	correlation	_
60-16	10763-10771	analysis	_
60-17	10772-10776	with	_
60-18	10777-10786	cognition	_
60-19	10787-10788	.	_

Text=The significance level was set at a cluster-level of p <0.05, and data were corrected for multiple comparisons with the family wise error (FWE) and a voxel-level threshold of p <0.005.
61-1	10789-10792	The	_
61-2	10793-10805	significance	_
61-3	10806-10811	level	_
61-4	10812-10815	was	_
61-5	10816-10819	set	_
61-6	10820-10822	at	_
61-7	10823-10824	a	_
61-8	10825-10838	cluster-level	_
61-9	10839-10841	of	_
61-10	10842-10843	p	_
61-11	10844-10845	<	_
61-12	10846-10850	0.05	_
61-13	10851-10852	,	_
61-14	10853-10856	and	_
61-15	10857-10861	data	_
61-16	10862-10866	were	_
61-17	10867-10876	corrected	_
61-18	10877-10880	for	_
61-19	10881-10889	multiple	_
61-20	10890-10901	comparisons	_
61-21	10902-10906	with	_
61-22	10907-10910	the	_
61-23	10911-10917	family	_
61-24	10918-10922	wise	_
61-25	10923-10928	error	_
61-26	10929-10930	(	_
61-27	10931-10934	FWE	_
61-28	10935-10936	)	_
61-29	10937-10940	and	_
61-30	10941-10942	a	_
61-31	10943-10954	voxel-level	_
61-32	10955-10964	threshold	_
61-33	10965-10967	of	_
61-34	10968-10969	p	_
61-35	10970-10971	<	_
61-36	10972-10977	0.005	_
61-37	10978-10979	.	_

